Multiple Sclerosis

Among multiple sclerosis (MS) patients, a combination of estriol and Copaxone (glatiramer acetate) reduced the rate of relapse by 50% percent within one year of treatment.

Honey bee venom is being used to treat pain for multiple sclerosis and osteoarthritis, according to a report from CBS News.

Among adult patients with multiple sclerosis (MS), pain severity can impact performance on cognitive tests, suggesting that pain independently contributes to impaired brain function in MS.

Patient characteristics and preferences and clinician risk tolerance are critically important guideposts in selecting among the various treatment choices for relapsing forms of multiple sclerosis.

With several clinical trials already underway, real hope for modifying the disease course of multiple sclerosis may come from strategies to remyelinate damaged neurons and brain cells.

Session at the 2014 AAN annual meeting contrasts a "tiered" treatment strategy that focuses on safety with a "maximal efficacy" approach and offers an in-depth review of the clinical benefits and potential side effects of the current array of treatments for multiple sclerosis.

A long-acting formulation of pegylated interferon beta was found be much more effective than placebo for people with relapsing-remitting multiple sclerosis.

Study data from two phase 3 clinical trials announced at AAN 2014 show sustained effects one year after two years of treatment with alemtuzumab in patient with MS.

Two-year data from the phase 3 ADVANCE study of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis show that more frequent dosing yields greater improvements, and that treatment with the drug is associated with a reduction in relapse rates, slower disease progression, and fewer T2 lesions compared to placebo.

Literature review by the AAN shows that oral and oral spray forms of medical marijuana effectively treat some symptoms of MS, but there is little evidence to support efficacy in treating other neurologic diseases such as Parkinson's disease, epilepsy, and Tourette syndrome.

Patients treated with ofatumumab, an anti-B cell antibody, for 24 weeks showed a significant reduction in disease activity, as measured by the appearance of new brain lesions.

An unexpectedly high number of cases of thrombotic microangiopathy has been reported in a small number of multiple sclerosis patients who are taking Rebif (interferon beta 1-alpha).

Researchers in the United Kingdom have shown a reduction in the rate of brain atrophy progression with use of 80-mg simvastatin daily in patients with secondary-progressive multiple sclerosis over a 2-year period.

Researchers at the National Institute of Neurological Disorders and Stroke may have found why patients taking the multiple sclerosis medication natalizumab (Tysabri) have a high risk of developing a rare brain infection that can be fatal.

Integrated clinical and specialty pharmacy practice model includes an interdisciplinary team of physicians, nurses, and pharmacists.

Two European clinical trials are both investigating a theory that multiple sclerosis may be triggered by activation of human endogenous retroviruses.

Researchers have discovered an association between depression and employment status in people with multiple sclerosis, according to a study published in Functional Neurology.

For multiple sclerosis patients, enrollment in an evidence-based education program resulted in more informed choices involving their condition, according to research published in the Journal of Neurology, Neurosurgery & Psychiatry.

Cutaneous reactions occurred in most participants in a Netherlands-based multiple sclerosis therapy study, lowering dermatologic-specific quality-of-life scores.

In addition to its recognized anti-inflammatory effects, dimethyl fumarate also produces antioxidative effects that may be neuroprotective.

Scientists from the University of Rostock in Germany explored the range of multiple sclerosis treatment options and examined them for possible infectious outcomes, side effects, and potential fatalities.